Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Curcumin  COVID-19 treatment studies for Curcumin  C19 studies: Curcumin  Curcumin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Hospitalization 31% Improvement Relative Risk Severe case 13% c19early.org/t Nimer et al. Curcumin for COVID-19 Prophylaxis Is prophylaxis with curcumin beneficial for COVID-19? Retrospective 2,148 patients in Jordan (March - July 2021) Lower hospitalization (p=0.08) and severe cases (p=0.47), not stat. sig. Nimer et al., F1000Research, doi:10.12688/f1000research.121933.1 Favors curcumin Favors control
Effect of natural products use prior to infection with COVID-19 on disease severity and hospitalization: A self-reported cross-sectional survey study
Nimer et al., F1000Research, doi:10.12688/f1000research.121933.1
Nimer et al., Effect of natural products use prior to infection with COVID-19 on disease severity and hospitalization: A.., F1000Research, doi:10.12688/f1000research.121933.1
Jun 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Survey 2,148 COVID-19 recovered patients in Jordan, showing lower hospitalization with turmeric prophylaxis, not reaching statistical significance.
Although the 31% lower hospitalization is not statistically significant, it is consistent with the significant 26% lower hospitalization [13‑37%] from meta analysis of the 9 hospitalization results to date.
risk of hospitalization, 30.8% lower, RR 0.69, p = 0.08, treatment 29 of 329 (8.8%), control 179 of 1,819 (9.8%), adjusted per study, odds ratio converted to relative risk, multivariable.
risk of severe case, 12.6% lower, RR 0.87, p = 0.47, treatment 40 of 329 (12.2%), control 211 of 1,819 (11.6%), adjusted per study, odds ratio converted to relative risk, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Nimer et al., 10 Jun 2022, retrospective, Jordan, peer-reviewed, survey, mean age 40.2, 4 authors, study period March 2021 - July 2021.
Contact: rmnimer@just.edu.jo.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperCurcuminAll
Abstract: F1000Research 2022, 11:639 Last updated: 06 JUL 2022 RESEARCH ARTICLE Effect of natural products use prior to infection with COVID-19 on disease severity and hospitalization: A self-reported crosssectional survey study [version 1; peer review: 2 approved with reservations] Refat M. Nimer , Omar F. Khabour , Samer F. Swedan, Hassan M. Kofahi Department of Medical Laboratory Sciences, Jordan University of Science and Technology, Irbid, 22110, Jordan v1 First published: 10 Jun 2022, 11:639 https://doi.org/10.12688/f1000research.121933.1 Latest published: 10 Jun 2022, 11:639 https://doi.org/10.12688/f1000research.121933.1 Abstract Background: Managing coronavirus disease 2019 (COVID-19) using available resources is essential to reduce the health burden of disease. The severity of COVID-19 is affected by nutritional status. In this study the effect of natural product use prior to infection with COVID-19 on disease severity and hospitalization was explored. Methods: This was a cross-sectional study. Between March and July 2021, a self-administered survey was conducted in Jordan. Individuals who recovered from COVID-19 and were ≥18 years old were the study population. Study measures included the use of natural products, COVID-19 severity, and hospitalization status. A multivariate regression model was used for statistical analysis. Results: The mean age (mean ± SD) of the study sample (n=2,148) was 40.25 ± 15.58 years old. Multivariate logistic regression showed that the regular intake of carnation (OR [0.56], CI [0.37–0.85]), onion (OR [0.69], CI [0.52–0.92]), lemon (OR [0.68], CI [0.51–0.90]), and citrus fruits (OR [0.66], CI [0.50–0.89]) before infection were associated with a substantial reduction in COVID-19 severity (P<0.01). Also, the consumption of carnation (OR [0.55], CI [0.34–0.88]), lemon (OR [0.57], CI [0.42–0.78]), and citrus fruits (OR [0.61], CI [0.44–0.84]) were associated with a significant decrease in the frequency of COVID-19induced hospitalization (P<0.01). Conclusions: Regular consumption of carnation, lemon, and citrus fruits before infection was associated with better outcomes for COVID-19. Studies on other populations are required to confirm these findings. Open Peer Review Approval Status version 1 10 Jun 2022 1 2 view view 1. Fatin Y. Atrooz, University of Houston, Houston, USA 2. Caterina Vicidomini, Istituto di Biostrutture e Bioimmagini IBB-CNR, Naples, Italy Any reports and responses or comments on the article can be found at the end of the article. Keywords COVID-19, natural products, carnation, onion, lemon, citrus, hospitalization, severity Page 1 of 16 F1000Research 2022, 11:639 Last updated: 06 JUL 2022 This article is included in the Emerging Diseases and Outbreaks gateway. This article is included in the Coronavirus collection. Corresponding author: Refat M. Nimer (rmnimer@just.edu.jo) Author roles: Nimer RM: Conceptualization, Funding Acquisition, Supervision, Writing – Original Draft Preparation; Khabour OF: Conceptualization, Validation, Writing – Review & Editing; Swedan SF: Data Curation, Formal Analysis, Validation, Writing – Review & Editing; Kofahi HM: Data Curation, Formal Analysis, Methodology, Validation, Writing – Review & Editing Competing interests: No competing interests were disclosed. Grant information: This work was supported by the Deanship of Research, Jordan University of Science and Technology (Grant number 20210173; to Dr. Refat Nimer). The funders had no role in..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit